Global Heart Valves Industry Forecast to 2028

Global Heart Valves Industry Forecast to 2028

Investments in Innovative Technologies Enable Growth Opportunities

RELEASE DATE
04-Apr-2024
REGION
North America
Deliverable Type
Market Research
Research Code: K9E5-01-00-00-00
SKU: HC_2024_640
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC_2024_640
$4,950.00
DownloadLink
ENQUIRE NOW

Description

In this analysis, Frost & Sullivan covers the heart valves industry, including aortic, mitral, tricuspid, and pulmonary valves. We address critical questions such as market sizes, growth rates, opportunities, strategic imperatives, technology impact, and untapped potential in the industry.

Our analysis shows that the industry is gaining traction due to the increasing adoption of transcatheter technologies. Transcatheter aortic valve replacement (TAVR) procedures recorded lucrative growth in the past few years and will continue to grow in the forecast period.

Industry participants are developing transcatheter mitral and tricuspid valve technologies to capture the next growth phase. Frost & Sullivan finds that the heart valves industry has reached an inflection point due to the development of many new technologies as well as the rise in clinical evidence and regulatory approval for these technologies.

Regional coverage includes North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa. North America is the largest market due to the presence of many large companies and emerging companies. The industry is growing rapidly in Asia-Pacific because of the high number of people suffering from heart valve diseases and growing awareness and accessibility to heart valve technologies.

The study period is 2021–2028, with 2023 as the base year and 2024–2028 as the forecast period.

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Heart Valves Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Heart Valves

Scope of Analysis

Segmentation

Segmentation: Product Examples

Key Competitors

Growth Environment

Summary

Growth Metrics

Growth Drivers

Growth Restraints

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Segment

Revenue Forecast by Region

Revenue Forecast Analysis

Revenue Forecast Analysis by Region

Pricing Trends and Forecast Analysis

Competitive Environment

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Company Mapping: Major Players

Company Mapping: Emerging Companies

Company Mapping: Emerging Companies (continued)

Heart Valve Diseases

Annuloplasty Rings Overview

Heart Valve Devices

TAVR in Young Patients

Expanding TAVR Applications

Demand for Tricuspid and Mitral Technologies

Europe Overview

Europe Overview (continued)

Asia-Pacific Overview

Patient Care Pathway

Patient Activation Increases New Opportunities

Patient Engagement

Patient Engagement (continued)

Technologies Affecting the Heart Valves Industry

Technologies Affecting the Heart Valves Industry (continued)

AI in Heart Valve Diseases

Start-ups in the Heart Valves Industry

Start-ups in the Heart Valves Industry (continued)

Heart Valves in Clinical Research

Heart Valves in Clinical Research (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Segment

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Segment

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Opportunity 1: Transcatheter Mitral and Tricuspid Valve Repair and Replacement

Growth Opportunity 1: Transcatheter Mitral and Tricuspid Valve Repair and Replacement (continued)

Growth Opportunity 2: Transcatheter Aortic Valve Replacement

Growth Opportunity 2: Transcatheter Aortic Valve Replacement (continued)

Growth Opportunity 3: Advanced Heart Valve Materials

Growth Opportunity 3: Advanced Heart Valve Materials (continued)

Growth Opportunity 4: Unmet Needs in Asia-Pacific

Growth Opportunity 4: Unmet Needs in Asia-Pacific (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

In this analysis, Frost & Sullivan covers the heart valves industry, including aortic, mitral, tricuspid, and pulmonary valves. We address critical questions such as market sizes, growth rates, opportunities, strategic imperatives, technology impact, and untapped potential in the industry. Our analysis shows that the industry is gaining traction due to the increasing adoption of transcatheter technologies. Transcatheter aortic valve replacement (TAVR) procedures recorded lucrative growth in the past few years and will continue to grow in the forecast period. Industry participants are developing transcatheter mitral and tricuspid valve technologies to capture the next growth phase. Frost & Sullivan finds that the heart valves industry has reached an inflection point due to the development of many new technologies as well as the rise in clinical evidence and regulatory approval for these technologies. Regional coverage includes North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa. North America is the largest market due to the presence of many large companies and emerging companies. The industry is growing rapidly in Asia-Pacific because of the high number of people suffering from heart valve diseases and growing awareness and accessibility to heart valve technologies. The study period is 2021 2028, with 2023 as the base year and 2024 2028 as the forecast period.
More Information
Deliverable Type Market Research
Author Utkarsha soundankar
Industries Healthcare
No Index No
Is Prebook No
Podcast No
WIP Number K9E5-01-00-00-00